BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24412604)

  • 21. Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals.
    Goikoetxea-Usandizaga N; Serrano-Maciá M; Delgado TC; Simón J; Fernández Ramos D; Barriales D; Cornide ME; Jiménez M; Pérez-Redondo M; Lachiondo-Ortega S; Rodríguez-Agudo R; Bizkarguenaga M; Zalamea JD; Pasco ST; Caballero-Díaz D; Alfano B; Bravo M; González-Recio I; Mercado-Gómez M; Gil-Pitarch C; Mabe J; Gracia-Sancho J; Abecia L; Lorenzo Ó; Martín-Sanz P; Abrescia NGA; Sabio G; Rincón M; Anguita J; Miñambres E; Martín C; Berenguer M; Fabregat I; Casado M; Peralta C; Varela-Rey M; Martínez-Chantar ML
    Hepatology; 2022 Mar; 75(3):550-566. PubMed ID: 34510498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease.
    Zhu H; Zhang Q; Chen G
    Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alleviation of Ischemia-Reperfusion Injury in Liver Steatosis by Augmenter of Liver Regeneration Is Attributed to Antioxidation and Preservation of Mitochondria.
    Weng J; Li W; Jia X; An W
    Transplantation; 2017 Oct; 101(10):2340-2348. PubMed ID: 28704337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers.
    Shaker ME; Trawick BN; Mehal WZ
    Biochem Pharmacol; 2016 Jul; 112():90-101. PubMed ID: 27157410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of ischaemic preconditioning on experimental steatotic livers following hepatic ischaemia-reperfusion injury: a systematic review.
    Chu MJ; Vather R; Hickey AJ; Phillips AR; Bartlett AS
    HPB (Oxford); 2015 Jan; 17(1):1-10. PubMed ID: 24712641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers.
    Liggett JR; Kang J; Ranjit S; Rodriguez O; Loh K; Patil D; Cui Y; Duttargi A; Nguyen S; He B; Lee Y; Oza K; Frank BS; Kwon D; Li HH; Kallakury B; Libby A; Levi M; Robson SC; Fishbein TM; Cui W; Albanese C; Khan K; Kroemer A
    Front Immunol; 2022; 13():898799. PubMed ID: 36148239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury.
    Baskin-Bey ES; Canbay A; Bronk SF; Werneburg N; Guicciardi ME; Nyberg SL; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G396-402. PubMed ID: 15472011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
    Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
    Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia-reperfusion injury.
    Li TH; Liu CW; Lee PC; Huang CC; Lee KC; Hsieh YC; Yang YY; Hsieh SL; Lin HC; Tsai CY
    J Chin Med Assoc; 2017 Jul; 80(7):391-400. PubMed ID: 28325574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemia reperfusion injury induces pyroptosis and mediates injury in steatotic liver thorough Caspase 1 activation.
    Kolachala VL; Lopez C; Shen M; Shayakhmetov D; Gupta NA
    Apoptosis; 2021 Jun; 26(5-6):361-370. PubMed ID: 33990906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion.
    Elias-Miró M; Mendes-Braz M; Cereijo R; Villarroya F; Jiménez-Castro MB; Gracia-Sancho J; Guixé-Muntet S; Massip-Salcedo M; Domingo JC; Bermudo R; Rodés J; Peralta C
    J Hepatol; 2014 Jan; 60(1):87-95. PubMed ID: 23968888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced inflammatory response and increased microcirculatory disturbances during hepatic ischemia-reperfusion injury in steatotic livers of ob/ob mice.
    Hasegawa T; Ito Y; Wijeweera J; Liu J; Malle E; Farhood A; McCuskey RS; Jaeschke H
    Am J Physiol Gastrointest Liver Physiol; 2007 May; 292(5):G1385-95. PubMed ID: 17307725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ankaflavin ameliorates steatotic liver ischemia-reperfusion injury in mice.
    Yang HJ; Tang LM; Zhou XJ; Qian J; Zhu J; Lu L; Wang XH
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):619-25. PubMed ID: 26663010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative Study on the Cytoprotective Effects of Activated Protein C Treatment in Nonsteatotic and Steatotic Livers under Ischemia-Reperfusion Injury.
    Matsuda A; Kuriyama N; Kato H; Tanemura A; Murata Y; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
    Biomed Res Int; 2015; 2015():635041. PubMed ID: 26539519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteasome inhibitors protect the steatotic and non-steatotic liver graft against cold ischemia reperfusion injury.
    Zaouali MA; Bardag-Gorce F; Carbonell T; Oliva J; Pantazi E; Bejaoui M; Ben Abdennebi H; Rimola A; Roselló-Catafau J
    Exp Mol Pathol; 2013 Apr; 94(2):352-9. PubMed ID: 23305864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial dysfunction in steatotic rat livers occurs because a defect in complex i makes the liver susceptible to prolonged cold ischemia.
    Chu MJ; Hickey AJ; Jiang Y; Petzer A; Bartlett AS; Phillips AR
    Liver Transpl; 2015 Mar; 21(3):396-407. PubMed ID: 25312517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histidine-Rich Glycoprotein Alleviates Liver Ischemia/Reperfusion Injury in Mice With Nonalcoholic Steatohepatitis.
    Guo J; Akahoshi T; Mizuta Y; Murata M; Narahara S; Kawano T; Nagao Y; Zhang S; Tomikawa M; Kawanaka H; Hashizume M
    Liver Transpl; 2021 Jun; 27(6):840-853. PubMed ID: 33259137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury.
    Hamada T; Duarte S; Tsuchihashi S; Busuttil RW; Coito AJ
    Am J Pathol; 2009 Jun; 174(6):2265-77. PubMed ID: 19443702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.
    Ellett JD; Evans ZP; Atkinson C; Schmidt MG; Schnellmann RG; Chavin KD
    Liver Transpl; 2009 Sep; 15(9):1101-9. PubMed ID: 19718644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adeno-Associated Virus-Mediated Gene Transfer of Tissue Inhibitor of Metalloproteinases-1 Impairs Neutrophil Extracellular Trap Formation and Ameliorates Hepatic Ischemia and Reperfusion Injury.
    Duarte S; Matian P; Ma S; Busuttil RW; Coito AJ
    Am J Pathol; 2018 Aug; 188(8):1820-1832. PubMed ID: 29870740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.